Pharmaceutical companies continue to market new drugs to combat excess weight. The FDA says that recent studies of Saxenda drug company Novo Nordisk has shown positive results in the fight against obesity. The Danes have managed to create a drug that could reduce weight in 31% of subjects more than 10% and 60% by 5%. In this case, improved the General condition of all subjects.
Soon the FDA wants to test the effectiveness of another drug to combat obesity company Orexigen Therapeutics. This company is not the only one that want to market their product. Developments are carried out in different countries, as the problem of obesity has affected almost all parts of the world.